DS
STOK icon

David Shaw’s Stoke Therapeutics STOK Stock Holding History

David Shaw’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Buy
57,847
+7,875
+16% +$253K ﹤0.01% 3251
2026
Q1 		$1.63M Buy
49,972
+71
+0.1% +$2.33K ﹤0.01% 3077
2025
Q4 		$1.58M Sell
49,901
-2,712
-5% -$81.5K ﹤0.01% 3225
2025
Q3 		$1.24M Buy
52,613
+21,917
+71% +$376K ﹤0.01% 3325
2025
Q2 		$348K Buy
+30,696
New +$291K ﹤0.01% 3799
2025
Q1 		– Sell
-28,043
Closed -$309K – 4727
2024
Q4 		$309K Sell
28,043
-143,203
-84% -$1.76M ﹤0.01% 3871
2024
Q3 		$2.1M Buy
171,246
+34,236
+25% +$485K ﹤0.01% 2673
2024
Q2 		$1.85M Sell
137,010
-56,750
-29% -$766K ﹤0.01% 2719
2024
Q1 		$2.62M Buy
193,760
+51,049
+36% +$309K ﹤0.01% 2418
2023
Q4 		$751K Sell
142,711
-62,455
-30% -$267K ﹤0.01% 3318
2023
Q3 		$808K Buy
205,166
+88,701
+76% +$583K ﹤0.01% 3181
2023
Q2 		$1.24M Buy
116,465
+50,496
+77% +$537K ﹤0.01% 2951
2023
Q1 		$550K Sell
65,969
-2,866
-4% -$25.9K ﹤0.01% 3513
2022
Q4 		$635K Buy
68,835
+42,700
+163% +$444K ﹤0.01% 3723
2022
Q3 		$336K Buy
+26,135
New +$416K ﹤0.01% 4250
2022
Q1 		– Sell
-10,065
Closed -$241K – 5920
2021
Q4 		$241K Buy
+10,065
New +$240K ﹤0.01% 4789
2021
Q3 		– Sell
-7,143
Closed -$240K – 5219
2021
Q2 		$240K Sell
7,143
-4,714
-40% -$167K ﹤0.01% 4384
2021
Q1 		$461K Buy
+11,857
New +$675K ﹤0.01% 3542

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

David Shaw's STOK Position: Q2 2026 in Review

David Shaw increased its Stoke Therapeutics (STOK) stake by 16% in Q2 2026, buying an estimated $253K and bringing the position to 57,847 shares worth $1.89M. The position accounts for ﹤0.01% of the portfolio, ranked #3251.

David Shaw first reported a position in STOK in Q1 2021 and has held it in 18 quarters since. The position peaked at $2.62M in Q1 2024. 196 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • David Shaw held 57,847 shares of Stoke Therapeutics worth $1.89M as of Q2 2026.
  • David Shaw bought 7,875 Stoke Therapeutics shares in Q2 2026, an estimated $253K.
  • Stoke Therapeutics made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3251 holding.
  • David Shaw first reported a position in Stoke Therapeutics in Q1 2021 and has held it in 18 quarters since.
  • David Shaw's Stoke Therapeutics position peaked at $2.62M in Q1 2024.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.